سعر كوينوستارماكس 750مجم 5 اقراص 2023

Quinostarmax 750 mg: levofloxacin 750 mg oral tablets (fluoroquinolone antibiotic) by Penta Pharma-Egypt, pack of 5.

• Community-acquired pneumonia (including the 5-day 750 mg regimen for susceptible organisms)Population: AdultsDailyMed (U.S. National Library of Medicine)
• Complicated and uncomplicated skin and skin-structure infectionsPopulation: AdultsDailyMed (U.S. National Library of Medicine)
• Chronic bacterial prostatitisPopulation: AdultsDailyMed (U.S. National Library of Medicine)

• Most common (>=3%): nausea, headache, diarrhoea, insomnia, constipation and dizziness.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to levofloxacin or other quinolone antibacterials.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: disabling and potentially irreversible serious adverse reactions (tendinitis and tendon rupture, peripheral neuropathy, CNS effects) and exacerbation of myasthenia gravis; discontinue immediately if these occur.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Tendon rupture risk higher in patients over 60, on corticosteroids or with kidney, heart or lung transplants.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Serious hypersensitivity, hepatotoxicity, haematologic and renal toxicity, Clostridioides difficile-associated diarrhoea and QT prolongation/torsade de pointes have been reported.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Antacids (Mg/Al), sucralfate, iron, zinc-containing multivitamins, didanosineChelation reduces absorption; separate doses by at least 2 hours.DailyMed (U.S. National Library of Medicine)

• Published case reports and observational studies have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal/fetal outcomes.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Present in human milk; a lactating woman may pump and discard milk during treatment and for 2 days after the last dose, or avoid breastfeeding over that period.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Levofloxacin: Inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV.